NPHC

 
Common Stock
OTC Pink Limited Information
Contact Info
  • 2776 University Drive
  • Coral Springs, FL 33065


Update Company Info
Business Description

Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Adrenomyeloneuropathy (AMN), Multiple Sclerosis (MS), and Human Immunodeficiency Virus (HIV). Additionally, the Company markets several drug products for sale for the treatment of pain under the brands Cobroxin and Nyloxin.

 
Financial Reporting/Disclosure
Reporting Status U.S. Registered & Reporting: SEC Filer
Audited Financials Audited
Latest Report Not Available
Regulatory Agency Not Available
CIK 0001119643
Fiscal Year End 12/31
OTC Market Tier OTC Pink Limited
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: CA, USA
Year of Inc. 2000
Employees Not Available
Company Officers
Rik Deitsch President, CEO, CFO
Company Directors
Not Available
Company Notes
  • Note=12-31-04 company is in the development stage
  • Formerly=Cyber-vitamin.com until 11-01
Service Providers
Auditor/Accountant
Kingery & Crouse, P.A.
2801 West Busch Blvd
Suite 200
Tampa, FL, 33618
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available
NPHC Security Details
Share Structure
Market Value1 $4,130,609 a/o May 23, 2012
Shares Outstanding 315,313,673 a/o Nov 09, 2011
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders
Shareholders of Record 259 a/o Apr 01, 2011
Short Selling Data
Short Interest 2,962 (-98.17%)
Mar 30, 2012
Significant Failures to Deliver No

1Market Value calculated only for respective security